Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results but Lilly is a Big Winner…Update-2
Best stock picks in large cap biopharma.
Overweight Healthcare Stocks As Uncertain Market Lies Ahead…Update-4
Update-4 Healthcare stocks hit hard with XLV down 0.77% to $133 handle. But CVS is down 8.43% on Caremark PBM trouble as Blue Shield moves to Amazon. UNH down 1.93% on disruption scenario with PBMs? Healthcare providers ETF IHF down 2.28% to $250: ==== Update-3 8/16 3:50 p Now the FEDspeak is...
Big Weeks Ahead for MedTech and Life Science Stocks …Update-4
Hot fun in the summertime! Will try to post a new article on Healthcare and Biotech tomorrow August 7. Update-4 Aug 3...Large cap biopharmas favored as spec stocks fade with XBI at $81 handle lacking momentum, near low for 30 days. Earnings looking good for large cap top picks REGN and...
Rayno BioBeat: Playbook Revisited as UNH Beat Could Help Sagging Healthcare Stocks…Update-2 rotation pivot
Update-2 Jy 22 Catch-up Rally last week continues in MedTech and Diagnostics: ABT our top pick up 5.89% to $114.29, DHR up 6.38% to $255.88,IHI up 1.32% to $57.59,TMO up 6.89% to $562. New Pick Becton Dickinson (BDX) up 2.1% to $264.84. Earnings coming next week for many MedTech stocks....
Biotech Blues: Stay Balanced Through July Earnings Season …Update-4 …JY 12: Biotech rally time!
Update-4 JY 12...Some biotech strength in usual suspects but exciting news drives smaller more speculative stocks. Recursion pharmaceuticals (RXRX) up 78% on $50M Nvidia drug discovery deal. As rumored AI meets biotech.Trading rally for sure as more AI plays likely. SMID favorites...